Mental Health Book



Aka: Midazolam, Versed
  1. See Also
    1. Benzodiazepine
    2. Procedural Sedation and Analgesia (PSAA)
    3. Rapid Sequence Intubation
  2. Indications
    1. Procedural Sedation and Analgesia (PSAA)
      1. Other agents are preferred in most cases (unpredictable)
    2. Rapid Sequence Intubation (induction agent)
      1. Other induction agents are preferred due to the large and unpredictable Midazolam doses required for induction
        1. Rarely given at adequate doses (a typical adult dose for RSI is an astounding 8-10 mg)
      2. Consider where IV Access unavailable or other intubation agents contraindicated
      3. Could be considered in Status Epilepticus (although Thiopental might be preferred)
  3. Class
    1. Parenteral short acting Benzodiazepine
  4. Mechanism
    1. Sedative, Anxiolytic, and amnestic effects
    2. Antagonist: Flumazenil
  5. Dosing: Procedural Sedation
    1. Indications for Midazolam
      1. Other sedation agents are preferred in most cases
      2. Intranasal Versed in children may allow for imaging, Intravenous Access, Laceration Repair
    2. Intravenous
      1. Age 6 months to 5 years
        1. Initial: 0.05 to 0.1 mg/kg IV
        2. Titrate: Up to 1 mg increments IV every 3 min to max of 0.6 mg/kg
      2. Age 6 to 12 years
        1. Initial: 0.025 to 0.05 mg/kg IV
        2. Titrate: Up to 1 mg increments IV every 3 min to max of 0.4 mg/kg
      3. Adults (and over age 12 years)
        1. Initial: 0.02 mg/kg IV
        2. Titrate: 1 mg increments IV every 3 min (typically up to 5 mg)
    3. Intramuscular
      1. Child: 0.1 to 0.15 mg/kg (up to 10 mg)
      2. Adult: 0.07 mg/kg (up to 10 mg)
    4. Other Dosing
      1. Oral: 0.5 mg/kg/dose
      2. Nasal: 0.2 to 0.5 mg/kg intranasal (1/2 in each nostril) using 5 mg/ml up to 10 mg
      3. Rectal 0.25 to 0.5 mg/kg/dose per Rectum
    5. Commonly used in combination with Fentanyl
      1. When combined with Opioids (e.g. Fentanyl), use lower Midazolam dose
      2. Risk of Deep Sedation with cardiopulmonary depression
  6. Safety
    1. Contraindicated in pregnancy (Category D)
    2. Wait at least 4 hours for Breast Feeding
    3. Unpredictable at increased doses (risk of respiratory and cardiovascular depression)
      1. Unreliable sedation for painful procedures
      2. Best delivered in incremental doses (e.g. 1 mg increments)
      3. Exercise extra caution in elderly, debilitated, children, hepatic insufficiency, Dementia
    4. Reversal: Flumazenil 0.01 mg/kg up to 2 mg over 15 seconds
      1. Do not use if on longterm Benzodiazepines
  7. Pharmacokinetics
    1. General
      1. Duration: 1-4 hours
      2. Half life: 2.5 hours
    2. Oral
      1. Onset: 20 to 30 minutes
      2. Peak: 40 minutes
    3. Intramuscular
      1. Onset: 5 to 7 minutes (up to 10-20 minutes)
      2. Peak: 10 to 15 minutes
      3. Duration: 60-120 minutes
    4. Intravenous
      1. Onset: 2-3 minutes
      2. Peak: 5 to 10 minutes
      3. Duration: 45-60 minutes
  8. Precautions
    1. Monitor closely with respiratory depression
    2. Have Ambubag and Oxygen available when administered
    3. Unpredictable at increased doses (risk of respiratory and cardiovascular depression)
      1. Best delivered in incremental doses (e.g. 1 mg increments)
      2. Risk of Hypotension
    4. Use with caution if risks for respiratory depression
      1. Elderly, debilitated patients or children
      2. Concurrent Narcotic use
      3. Existing CNS depression
      4. Chronic lung disease
      5. Neuromuscular disorder
      6. Apnea history
    5. Risk of Agitation
      1. Elderly
      2. Liver disease
  9. References
    1. Miner (2012) APLS Lecture, HCMC, Minneapolis
    2. Hamilton (2012) Tarascon Pharmacopeia, Jones and Bartlett, Burlington
    3. Rispoli (2002) Tarascon Pocket Orthopedics, Loma Linda, p. 115
    4. University Minnesota Childrens - Pediatric Emergency Drug Card
    5. Becker (2012) Anesth Prog 59:28-42 [PubMed]
    6. Brown (2005) Am Fam Physician 71:85-90 [PubMed]
    7. Singh in Blaivas (2012) Emergency Medicine - an International Perspective, p. 199-208
Medication Costs
midazolam (on 10/19/2016 at Medicaid.Gov Pharmacy Drug pricing)
MIDAZOLAM HCL 2 MG/2 ML VIAL Generic $0.28 per ml
MIDAZOLAM HCL 2 MG/ML SYRUP Generic $0.75 per ml
FPNotebook does not benefit financially from showing this medication data or their pharmacy links. This information is provided only to help medical providers and their patients see relative costs. Insurance plans negotiate lower medication prices with suppliers. Prices shown here are out of pocket, non-negotiated rates. See Needy Meds for financial assistance information.

Midazolam (C0026056)

Definition (NCI_NCI-GLOSS) A drug used to treat anxiety and tension and to relax muscles. It is also being studied in the treatment of nausea and vomiting caused by some cancer treatments. It is a type of benzodiazepine.
Definition (NCI) A short-acting benzodiazepine derivative with an imidazole structure and with anxiolytic, amnestic, hypnotic, anticonvulsant and sedative properties. Midazolam exerts its effect by binding to the benzodiazepine receptor at the gamma-aminobutyric acid (GABA) receptor-chloride ionophore complex in the central nervous system (CNS). This leads to an increase in the opening of chloride channels, membrane hyperpolarization and increases the inhibitory effect of GABA in the CNS. Midazolam may also interfere with the reuptake of GABA, thereby causing accumulation of GABA in the synaptic cleft.
Definition (MSH) A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
Definition (CSP) 8-chloro-6-(2-fluorophenyl)-1-methyl- 4H- imidazo(1,5a)(1,4)benzodiazepine; short acting benzodiazepine sedative with high liability for abuse; used for preanesthesia sedation (USP lists as an injectable anesthetic).
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D008874
SnomedCT 26800000, 373476007
LNC LP16207-0, MTHU003397
English Midazolam, 4H-Imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, 8-Chloro-6-(2-fluorophenyl)-1-Methyl- 4H- Imidazo(1,5a)(1,4)Benzodiazepine, midazolam (medication), sedatives midazolam, Midazolam [Chemical/Ingredient], MIDAZOLAM, midazolam, Midazolam (product), Midazolam (substance)
Swedish Midazolam
Czech midazolam
Finnish Midatsolaami
Japanese ミダゾラム
Polish Midazolam
Spanish midazolam (producto), midazolam (sustancia), midazolam, Midazolam
French Midazolam
German Midazolam
Italian Midazolam
Portuguese Midazolam
Derived from the NIH UMLS (Unified Medical Language System)

Versed (C0042553)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH D008874
English versed, vers, Versed
Derived from the NIH UMLS (Unified Medical Language System)

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree